Skip to main content

Day: September 8, 2025

Changes in Siili’s management team

Written by Customer Service on . Posted in Public Companies.

Changes in Siili’s management team Siili Solutions Plc Stock exchange release 8 September 2025 at 8:50 EEST Siili Solutions Plc (“Siili” or “company”) announced 12 August 2025 that it will renew its operational model and organization to be more in line with the Siili Group strategy and customer needs created by the AI transformation. As part of the organizational change Siili has appointed Markku Savusalo (VP, Digital Engineering), Jaakko Aatola (VP, Strategy & Partners) and Marton Heves (CEO, Supercharge Kft) as new members of Siili Solutions Plc’s management team effective as of 15 September 2025. At the same time, Andras Tessenyi will leave his position as the CEO of Supercharge Kft and as a member of Siili Group’s management team. Savusalo has previously worked as the director of Siili’s Services business unit. Aatola has previously...

Continue reading

Announcement of public offering of shares of Nordic Fibreboard AS

Written by Customer Service on . Posted in Public Companies.

Nordic Fibreboard AS (registry code: 11421437, address: Rääma tn 31, Pärnu, 80044 Estonia; the Company) hereby announces the additional public offering of its shares. Only existing shareholders of the Company are entitled to participate in the offering, who will be granted pre-emptive subscription rights in proportion to the number of shares held by them. The offering is based on an information document prepared by the Company, which is available on the Company’s website: https://www.nordicfibreboard.com/investor/stock-information/. The information document has been prepared in accordance with Article 1(4)(db) of Regulation (EU) 2017/1129 of the European Parliament and of the Council (the “Prospectus Regulation“), including the information set out in Annex IX to the Prospectus Regulation. Accordingly, no prospectus for...

Continue reading

Burning Rock Reports Second Quarter 2025 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

GUANGZHOU, China, Sept. 08, 2025 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2025. Second Quarter 2025 Financial Results Total Revenues were RMB148.5 million (US$20.7 million) for the three months ended June 30, 2025, representing a 9.6% increase from RMB135.5 million for the same period in 2024.Revenue generated from in-hospital business was RMB62.5 million (US$8.7 million) for the three months ended June 30, 2025, representing a 4.4% increase from RMB59.9 million for the same period in 2024, driven by an increase in sales volume from existing hospitals and new contracted partner hospitals. Revenue...

Continue reading

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Unseen Interior and Product Highlights of the FX Super One to Be Unveiled on 919 Futurist Day & Shareholders’ Day

Written by Customer Service on . Posted in Public Companies.

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor UpdateFaraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Unseen Interior and Product Highlights of the FX Super One to Be Unveiled on 919 Futurist Day & Shareholders’ DayNumerous Company updates will be given at the 919 event including details on C10 & C (Crypto), the Company’s three growth engines, including the C10 Treasury; its roadmap for capital value realization; and the deployment strategy for FF EAI Vehicle Chain products.LOS ANGELES, Sept. 07, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today shared a weekly business update from YT Jia, Founder and Global...

Continue reading

InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore

Written by Customer Service on . Posted in Public Companies.

HIBRUKA (Orelabrutinib)Approval of HIBRUKA (Orelabrutinib) for the Treatment of R/R MZL in SingaporeBEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA (orelabrutinib) has been approved by the Health Sciences Authority (HSA) of Singapore for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (R/R MZL). Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare said, “We are excited to obtain a second indication approval in Singapore. As a highly selective BTK inhibitor, orelabrutinib has demonstrated good efficacy and safety in the treatment of R/R MZL. The approval in Singapore will offer a new treatment option to local lymphoma patients. In addition...

Continue reading

ACM Research Delivered Its First High-Throughput Ultra Lith KrF Track System to a Leading Chinese Logic Wafer Fab Customer

Written by Customer Service on . Posted in Public Companies.

New Ultra Lith KrF Track System Delivers High-Throughput Performance with Proprietary Platform Design, Driving Advanced Process Control for Mature-node Lithography Applications FREMONT, Calif., Sept. 07, 2025 (GLOBE NEWSWIRE) —  ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer and panel processing solutions for semiconductor and advanced packaging applications, today announced the launch of its first Ultra Lith KrF track system, designed to support front-end semiconductor manufacturing. The new system expands ACM’s lithography product line and delivers high-throughput performance, advanced thermal control, and real-time process control and monitoring. The first system was shipped to a leading Chinese logic wafer fab customer in September 2025. ACM’s Ultra Lith KrF track system builds on the proven architecture...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.